{
  "pmid": "25455093",
  "uid": "25455093",
  "title": "GFR decline as an alternative end point in clinical trials to prevent ESRD: are we increasing treatment uncertainty for the sake of feasibility?",
  "abstract": "",
  "authors": [
    {
      "last_name": "Sontrop",
      "fore_name": "Jessica M",
      "initials": "JM",
      "name": "Jessica M Sontrop",
      "affiliations": []
    },
    {
      "last_name": "Al-Jaishi",
      "fore_name": "Ahmed A",
      "initials": "AA",
      "name": "Ahmed A Al-Jaishi",
      "affiliations": []
    },
    {
      "last_name": "Garg",
      "fore_name": "Amit X",
      "initials": "AX",
      "name": "Amit X Garg",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "American journal of kidney diseases : the official journal of the National Kidney Foundation",
    "iso_abbreviation": "Am J Kidney Dis",
    "issn": "1523-6838",
    "issn_type": "Electronic",
    "volume": "64",
    "issue": "6",
    "pub_year": "2014",
    "pub_month": "Dec"
  },
  "start_page": "841",
  "end_page": "844",
  "pages": "841-4",
  "language": "eng",
  "publication_types": [
    "Editorial",
    "Comment"
  ],
  "keywords": [
    "Endpoint Determination",
    "Glomerular Filtration Rate",
    "Humans",
    "Kidney Failure, Chronic",
    "Randomized Controlled Trials as Topic"
  ],
  "article_ids": {
    "pubmed": "25455093",
    "doi": "10.1053/j.ajkd.2014.10.002",
    "pii": "S0272-6386(14)01266-9"
  },
  "doi": "10.1053/j.ajkd.2014.10.002",
  "dates": {
    "completed": "2015-02-06",
    "revised": "2018-12-02"
  },
  "chemicals": [],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:22:09.171472",
    "pmid": "25455093"
  }
}